BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27398412)

  • 1. Involvement of Nucleophosmin (NPM1/B23) in Assembly of Infectious HPV16 Capsids.
    Day PM; Thompson CD; Pang YY; Lowy DR; Schiller JT
    Papillomavirus Res; 2015 Dec; 1():74-89. PubMed ID: 27398412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.
    Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L
    J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.
    Chen J; Wang D; Wang Z; Wu K; Wei S; Chi X; Qian C; Xu Y; Zhou L; Li Y; Zhang S; Li T; Kong Z; Wang Y; Zheng Q; Yu H; Zhao Q; Zhang J; Xia N; Li S; Gu Y
    J Virol; 2023 Mar; 97(3):e0181922. PubMed ID: 36815785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism.
    Day PM; Thompson CD; Lowy DR; Schiller JT
    J Virol; 2017 May; 91(10):. PubMed ID: 28250129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.
    Roden RB; Greenstone HL; Kirnbauer R; Booy FP; Jessie J; Lowy DR; Schiller JT
    J Virol; 1996 Sep; 70(9):5875-83. PubMed ID: 8709207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.
    Hagensee ME; Yaegashi N; Galloway DA
    J Virol; 1993 Jan; 67(1):315-22. PubMed ID: 8380079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
    Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process.
    DiGiuseppe S; Bienkowska-Haba M; Guion LGM; Keiffer TR; Sapp M
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging.
    Cerqueira C; Pang YY; Day PM; Thompson CD; Buck CB; Lowy DR; Schiller JT
    J Virol; 2016 Jan; 90(2):1096-107. PubMed ID: 26559838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of human papillomavirus type 16 L2 with cellular proteins: identification of novel nuclear body-associated proteins.
    Görnemann J; Hofmann TG; Will H; Müller M
    Virology; 2002 Nov; 303(1):69-78. PubMed ID: 12482659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of B23/NPM1 in Viral Infections, Potential Uses of B23/NPM1 Inhibitors as Antiviral Therapy.
    Lobaina Y; Perera Y
    Infect Disord Drug Targets; 2019; 19(1):2-16. PubMed ID: 29589547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus 16 minor capsid protein L2 helps capsomeres assemble independently of intercapsomeric disulfide bonding.
    Ishii Y; Ozaki S; Tanaka K; Kanda T
    Virus Genes; 2005 Dec; 31(3):321-8. PubMed ID: 16175337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection.
    Cruz L; Biryukov J; Conway MJ; Meyers C
    Viruses; 2015 Nov; 7(11):5813-30. PubMed ID: 26569287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between papillomavirus L1 and L2 capsid proteins.
    Finnen RL; Erickson KD; Chen XS; Garcea RL
    J Virol; 2003 Apr; 77(8):4818-26. PubMed ID: 12663788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-L1 antibody-bound HPV16 pseudovirus is degraded intracellularly via TRIM21/proteasomal pathway.
    Li M; Huang J; Zhu Y; Huang Z; Zhang G; Huang J
    Virol J; 2022 May; 19(1):90. PubMed ID: 35619167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection.
    Day PM; Weisberg AS; Thompson CD; Hughes MM; Pang YY; Lowy DR; Schiller JT
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.
    Heino P; Dillner J; Schwartz S
    Virology; 1995 Dec; 214(2):349-59. PubMed ID: 8553535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar protein NPM1 is essential for circovirus replication by binding to viral capsid.
    Zhou J; Dai Y; Lin C; Zhang Y; Feng Z; Dong W; Jin Y; Yan Y; Zhou J; Gu J
    Virulence; 2020 Dec; 11(1):1379-1393. PubMed ID: 33073687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of TRAPPC8 as a host factor required for human papillomavirus cell entry.
    Ishii Y; Nakahara T; Kataoka M; Kusumoto-Matsuo R; Mori S; Takeuchi T; Kukimoto I
    PLoS One; 2013; 8(11):e80297. PubMed ID: 24244674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparative Study on Delivery of Externally Attached DNA by Papillomavirus VLPs and Pseudoviruses.
    Brendle S; Cladel N; Balogh K; Alam S; Christensen N; Meyers C; Hu J
    Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.